Celcuity CELC
NASDAQ CELC
$95.70 -0.73 (-0.76%)
As of: Sep 4, 2026 · 3:59 PM EDT

Celcuity (CELC) Cash from Operations (2016 - 2025)

Celcuity's (CELC) quarterly Cash from Operations came in at 36399000.0 in Q4 2025, down 31.07% YoY from 52808120.27 in Q4 2024, and up 18.78% on a QoQ basis from 44816000.0 in Q3 2025.

Analysis

Celcuity (CELC) Cash from Operations (2016 - 2025) Analysis & Trends

Celcuity (CELC) has 10 years of Cash from Operations data on file, last reported at 36399000.0 in Q4 2025.

  • Quarterly Cash from Operations fell 31.07% year-over-year to 36399000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 153280000.0 (down 83.64% YoY) and the FY2025 annual result came in at 153280000.0, down 83.64% from the prior year.
  • Cash from Operations advanced to 36399000.0 in Q4 2025, from 44816000.0 in the prior quarter.
  • In the past five years, Cash from Operations ranged from a high of 2521505.0 in Q1 2021 to a low of 44816000.0 in Q3 2025.
  • A 5-year average of 17343968.2 and a median of 12807140.0 in 2023 frame the typical range for Cash from Operations.
  • Annual changes were most pronounced in 2021 — Cash from Operations slumped 389.56% — and 2023, when it increased 14.41%.
  • Tracing CELC's Cash from Operations over 5 years: stood at 6124002.0 in 2021, then plunged by 54.79% to 9479260.0 in 2022, then plunged by 95.54% to 18535921.0 in 2023, then tumbled by 49.82% to 27770000.0 in 2024, then plunged by 31.07% to 36399000.0 in 2025.
  • The last three Cash from Operations figures came in at 36399000.0 (Q4 2025), 44816000.0 (Q3 2025), and 36212000.0 (Q2 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Operations (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 1.13 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 813.00 Mn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -526.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - -387.32 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 462.82 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 326.72 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 728.46 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn -88.83 Mn
10 Celcuity 5.25 Bn 5.25 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 -36.40 Mn
Sep 30, 2025 -44.82 Mn
Jun 30, 2025 -36.21 Mn
Mar 31, 2025 -35.85 Mn
Dec 31, 2024 -27.77 Mn
Sep 30, 2024 -20.56 Mn
Jun 30, 2024 -18.07 Mn
Mar 31, 2024 -17.07 Mn
Dec 31, 2023 -18.54 Mn
Sep 30, 2023 -12.75 Mn
Jun 30, 2023 -9.66 Mn
Mar 31, 2023 -12.87 Mn
Dec 31, 2022 -9.48 Mn
Sep 30, 2022 -9.31 Mn
Jun 30, 2022 -11.29 Mn
Mar 31, 2022 -5.93 Mn
Dec 31, 2021 -6.12 Mn
Sep 30, 2021 -4.05 Mn
Jun 30, 2021 -7.62 Mn
Mar 31, 2021 -2.52 Mn